Drug Royalty Corp., Phytogen deal

DRI invested C$3 million (US$2.16 million) in Phytogen, bringing DRI's total investment in the company

Read the full 154 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE